NOMADAR CORP-A (NOMA) Stock Fundamental Analysis

NASDAQ:NOMA • US65531Y1064

4.16 USD
-0.25 (-5.67%)
Last: Feb 25, 2026, 02:41 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NOMA. NOMA was compared to 80 industry peers in the Entertainment industry. While NOMA seems to be doing ok healthwise, there are quite some concerns on its profitability. NOMA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year NOMA has reported negative net income.
NOMA Yearly Net Income VS EBIT VS OCF VS FCFNOMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -200K -400K -600K -800K -1M

1.2 Ratios

  • NOMA has a Return On Assets of -13.05%. This is in the lower half of the industry: NOMA underperforms 73.75% of its industry peers.
  • Looking at the Return On Equity, with a value of -25.37%, NOMA is doing worse than 61.25% of the companies in the same industry.
Industry RankSector Rank
ROA -13.05%
ROE -25.37%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOMA Yearly ROA, ROE, ROICNOMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

  • NOMA's Gross Margin of 21.25% is on the low side compared to the rest of the industry. NOMA is outperformed by 77.50% of its industry peers.
  • NOMA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NOMA Yearly Profit, Operating, Gross MarginsNOMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 -5K -10K -15K

5

2. Health

2.1 Basic Checks

  • The number of shares outstanding for NOMA remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, NOMA has a worse debt to assets ratio.
NOMA Yearly Shares OutstandingNOMA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 5M 10M
NOMA Yearly Total Debt VS Total AssetsNOMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 100K 200K 300K 400K

2.2 Solvency

  • NOMA has an Altman-Z score of 6.58. This indicates that NOMA is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 6.58, NOMA belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
  • NOMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.58
ROIC/WACCN/A
WACCN/A
NOMA Yearly LT Debt VS Equity VS FCFNOMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 -500K -1M

2.3 Liquidity

  • A Current Ratio of 0.06 indicates that NOMA may have some problems paying its short term obligations.
  • With a Current ratio value of 0.06, NOMA is not doing good in the industry: 93.75% of the companies in the same industry are doing better.
  • NOMA has a Quick Ratio of 0.06. This is a bad value and indicates that NOMA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NOMA has a worse Quick ratio (0.06) than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
NOMA Yearly Current Assets VS Current LiabilitesNOMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200K 400K 600K 800K

0

3. Growth

3.1 Past

  • NOMA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3450.00%.
EPS 1Y (TTM)-3450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NOMA Yearly Revenue VS EstimatesNOMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2K 4K 6K

0

4. Valuation

4.1 Price/Earnings Ratio

  • NOMA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOMA Price Earnings VS Forward Price EarningsNOMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOMA Per share dataNOMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for NOMA!.
Industry RankSector Rank
Dividend Yield 0%

NOMADAR CORP-A

NASDAQ:NOMA (2/25/2026, 2:41:49 PM)

4.16

-0.25 (-5.67%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners5.77%
Ins Owner Change0%
Market Cap63.11M
Revenue(TTM)8.00K
Net Income(TTM)-1.37M
AnalystsN/A
Price TargetN/A
Short Float %1.14%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7888.4
P/FCF N/A
P/OCF N/A
P/B 11.66
P/tB 11.66
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.05%
ROE -25.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.25%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z 6.58
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3373.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1189.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1189.43%
OCF growth 3YN/A
OCF growth 5YN/A

NOMADAR CORP-A / NOMA FAQ

What is the fundamental rating for NOMA stock?

ChartMill assigns a fundamental rating of 1 / 10 to NOMA.


Can you provide the valuation status for NOMADAR CORP-A?

ChartMill assigns a valuation rating of 0 / 10 to NOMADAR CORP-A (NOMA). This can be considered as Overvalued.


How profitable is NOMADAR CORP-A (NOMA) stock?

NOMADAR CORP-A (NOMA) has a profitability rating of 0 / 10.